PBTK modeling of potential endocrine modulators: In vitro-in vivo extrapolation (IVIVE) and in silico-in vitro based risk assessments

被引：0
|
作者：
Fabian, E. [1 ]
Haase, C. [1 ]
Ramirez, T. [1 ]
Gomes, C. [1 ]
Birk, B. [1 ]
van Ravenzwaay, B. [1 ]
Landsiedel, R. [1 ]
机构：
[1] BASF SE, Expt Toxicol & Ecol, Ludwigshafen, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2017年 / 390卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P265
引用
收藏
页码：S79 / S79
页数：1
相关论文
共 50 条
  • [31] Physiologically based approaches towards the prediction of pharmacokinetics:: in vitro-in vivo extrapolation
    De Buck, Stefan S.
    Mackie, Claire E.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2007, 3 (06) : 865 - 878
  • [32] An in vitro-in silico-in vivo approach to predicting the oral pharmacokinetic profile of salts of weak acids: Case example dantrolene
    Kambayashi, Atsushi
    Dressman, Jennifer B.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2013, 84 (01) : 200 - 207
  • [33] Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach
    Fei, Yang
    Kostewicz, Edmund S.
    Sheu, Ming-Thau
    Dressman, Jennifer B.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2013, 85 (03) : 1274 - 1284
  • [34] APPLICATION OF IN VITRO-IN VIVO EXTRAPOLATION (IVIVE) TO INVESTIGATE THE RATE-DETERMINING STEPS IN THE HEPATIC CLEARANCE OF HIV PROTEASE INHIBITORS IN RAT
    De Bruyn, Tom
    Augustijns, Patrick
    Annaert, Pieter
    DRUG METABOLISM REVIEWS, 2014, 45 : 165 - 165
  • [35] In Vitro-In Vivo Extrapolation (IVIVE) of Genetic Toxicity New Approach Methodology (NAM) Data: A HESI-GTTC Case Study
    Long, Alexandra S.
    Beal, Marc A.
    Sangion, Alessandro
    Armitage, James
    Arnot, Jon
    White, Paul A.
    Barton-Maclaren, Tara S.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2023, 64 : 46 - 47
  • [36] In Vitro-In Vivo Extrapolation by Physiologically Based Kinetic Modeling: Experience With Three Case Studies and Lessons Learned
    Algharably, Engi Abdelhady
    Di Consiglio, Emma
    Testai, Emanuela
    Pistollato, Francesca
    Mielke, Hans
    Gundert-Remy, Ursula
    FRONTIERS IN TOXICOLOGY, 2022, 4
  • [37] Analysis of Time-Dependent Pharmacokinetics Using In Vitro-In Vivo Extrapolation and Physiologically Based Pharmacokinetic Modeling
    Kim, Min-Chang
    Lee, Young-Joo
    PHARMACEUTICS, 2022, 14 (12)
  • [38] Application of in vitro-in vivo extrapolation (IVIVE) and physiologically based pharmacokinetic (PBPK) modelling to investigate the impact of the CYP2C8 polymorphism on rosiglitazone exposure
    Karen Rowland Yeo
    Jane R. Kenny
    Amin Rostami-Hodjegan
    European Journal of Clinical Pharmacology, 2013, 69 : 1311 - 1320
  • [39] Integration of mechanism-based in vitro methods and quantitative in vitro-in vivo extrapolation (QIVIVE) modelling for prediction of nephrotoxicity
    Mally, A.
    Birk, B.
    DiFiore, S.
    Ellinger, B.
    Jarzina, S.
    Taverne, F.
    Kramer, N.
    TOXICOLOGY LETTERS, 2018, 295 : S27 - S27
  • [40] In Vitro-In Vivo Correlation Using In Silico Modeling of Physiological Properties, Metabolites, and Intestinal Metabolism
    Choi, Sung-Min
    Kang, Chin-Yang
    Lee, Beom Jin
    Park, Jun-Bom
    CURRENT DRUG METABOLISM, 2017, 18 (11) : 973 - 982
12345